Product NameCitation
References for ARv7 Splice Variant antibody [RM7]Brady L et al Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling. Nat Commun. (2021), 10.1038/s41467-021-21615-4. IHC; Human. Read more (PubMed: 33658518)

Sugiura M et al. Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer. Transl Oncol. (2020), 10.1016/j.tranon.2020.100915. WB; Human. Read more (PubMed: 33096335)

Xu S et al. p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer. Cancer Res. (2020), 10.1158/0008-5472.CAN-20-0233. WB; Human. Read more (PubMed: 32522824)

Yoshizawa A et al. Combined a-methylacyl-CoA racemase inhibition and docetaxel treatment reduce cell proliferation and decrease expression of heat shock protein 27 in androgen receptor-variant-7epositive prostate cancer cells.. Prostate International. (2020), 10.1016/j.prnil.2020.07.001. WB; Human. Read more (Prostate International)

Labib M et al. Tracking the expression of therapeutic protein targets in rare cells by antibody-mediated nanoparticle labelling and magnetic sorting. Nat Biomed Eng. (2020), 10.1038/s41551-020-0590-1. FC; Human. Read more (PubMed: 32719513)

Hirayama Y et al. Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer. Mol Oncol. (2020), 10.1002/1878-0261.12770. WB; Human. Read more (PubMed: 32734688)

Gjyrezi A et al. Taxane resistance in prostate cancer is mediated by decreased drug-target engagement. J Clin Invest. (2020), 10.1172/JCI132184. IHC; Human. Read more (PubMed: 32478682)

Nappi L et al. Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models. J Clin Invest. (2020), 10.1172/JCI130819. WB; Human. Read more (PubMed: 31845908)

Ylitalo EB et al. Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens. Prostate. (2020), 10.1002/pros.23935. IHC; Human. Read more (PubMed: 31799745)

Lu C et al. Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations. Prostate. (2020), 10.1038/s41391-020-0217-3. IHC; Human. Read more (PubMed: 32139878)

Berger A et al. N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer. J Clin Invest. (2019), 10.1172/JCI127961. WB; Human. Read more (PubMed: 31260412)

Sharp A et al. Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer. Eur Urol. (2019), 10.1016/j.eururo.2019.04.006. IHC; Human. Read more (PubMed: 31036442)

Zadra G et al. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer. Proc Natl Acad Sci U S A. (2019), 10.1073/pnas.1808834116. IHC, WB; Human. Read more (PubMed: 30578319)

Sowalsky AG et al. Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations. Cancer Res. (2018), 10.1158/0008-5472.CAN-18-0610. IHC, ISH; Human. Read more (PubMed: 29921690)

Cato L et al. ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer. Cancer Cell. (2019), 10.1016/j.ccell.2019.01.008. IHC-F, WB; Human. Read more (PubMed: 30773341)

Bai S et al. A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer. Oncogene. (2019), 10.1038/s41388-019-0768-8. WB; Human. Read more (PubMed: 30820039)

Sharp A et al. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer. J Clin Invest. (2018) 10.1172/JCI122819. IHC-P, IP, WB; Human. Read more (PubMed: 30334814)

Zhao P et al. Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications. Asian J Urol. (2018), 10.1016/j.ajur.2018.09.003. WB, IHC-P; Human. Read more (Asian J Urol. AJUR244)

Russo JW et al. Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer. Cancer Res. (2018), 10.1158/0008-5472.CAN-18-0687. IHC-P; Human. Read more (PubMed: 30242112)

Yang RK et al. Expression pattern of androgen receptor and AR-V7 in androgen deprivation therapy naïve salivary duct carcinomas. Hum Pathol. (2018), 10.1016/j.humpath.2018.09.009. IHC-P; Human. Read more (PubMed: 30267779)

Lawrence MG et al. Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy. Eur Urol. (2018) 10.1016/j.eururo.2018.06.020. IHC-P; Human. Read more (PubMed: 30049486)

Kallio HML et al. Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases. Br J Cancer. (2018) 10.1038/s41416-018-0172-0. IHC-P; Human. Read more (PubMed: 29988112)

Zhao Pet al. Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma by immunohistochemistry. American Association for Cancer Research. (2018) 10.1158/1538-7445.AM2018-2640. IHC-P; Human. Read more (AACR 2018 Abstracts: 2640)

Miao L et al. Disrupting androgen receptor signaling induces Snail-mediated epithelial-mesenchymal plasticity in prostate cancer. Cancer Res. (2017) 10.1158/0008-5472.CAN-16-2169. WB; Human. Read more (PubMed: 28302679)

Moon SJ et al. DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7. Oncogene (2018) 10.1158/0008-5472.CAN-16-2169. WB; Human. IP; Human. ChIP; Human. Read more (PubMed: 29249800)

Zhu Y et al. Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer. Eur Urol. (2017) 10.1016/j.eururo.2017.08.009. WB; Human. IHC-P; Human. Read more (PubMed: 28866255)

Luo J et al. Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting. Eur Urol. (2017) 10.1016/j.eururo.2017.11.038. WB; Human. IHC-P; Human. ChIP; Human. Read more (PubMed: 29258679)

J Luo et al. Noninvasive Detection of AR-FL/AR-V7 as a Predictive Biomarker for Therapeutic Resistance in Men with Metastatic Castration-Resistant Prostate Cancer. U.S. Army Medical Research and Materiel Command (2018) AWARD NUMBER: W81XWH-15-2-0050. WB, IHC, IP, ChIP; Human. Read More
References for 6x His-Tag or 10x His-Tag antibody (RM146)Goto S et al Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models. Cancer Immunol Immunother. (2021), 10.1007/s00262-021-02853-3. FC; Human. Read more (PubMed: 33559069)
References for Histone H3 K27M Mutant antibody [RM192]Thomas L et al OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma. J Transl Med. (2020), 10.1186/s12967-020-02593-5. IHC; Human. Read more (PubMed: 33168005)

Minasi S et al Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma. Childs Nerc Syst. (2020), 10.1007/s00381-020-04933-8. IHC; Human. Read more (PubMed: 33128602)

Mondal G et al Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol. (2020), 10.1007/s00401-020-02155-5. IHC; Human. Read more (PubMed: 32303840)

Maeda S et al H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant. Acta Neuropathol Commun. (2020), 10.1186/s40478-020-0882-4. WB, IHC; Human. Read more (PubMed: 32019606)

Chiang J et al Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG. Acta Neuropathol Commun. (2020), 10.1186/s40478-020-00930-9. IHC; Human. Read more (PubMed: 32326973)

Tanrıkulu B et al Is H3K27me3 status really a strong prognostic indicator for pediatric posterior fossa ependymomas? A single surgeon, single center experience. Childs Nerv Syst. (2020), 10.1007/s00381-020-04518-5. IHC-F; Human. Read more (PubMed: 32025869)

Qiu T et al Imaging characteristics of adult H3 K27M-mutant gliomas. J Neurosurg. (2019), 10.3171/2019.9.JNS191920. IHC; Human. Read more (PubMed: 31731269)

Pathania M et al. H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas Cancer Cell (2017) 10.1016/j.ccell.2017.09.014. IHC-P; Human. Read more (PubMed: 29107533)
References for Histone H3 K36M Mutant antibody [RM193]Papke D J et al. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma. Mod Pathol. (2020), 10.1038/s41379-020-0604-2. IHC; Human. Read more (PubMed: 32601382)

Brumbaugh J et al. Inducible histone K-to-M mutations are dynamic tools to probe the physiological role of site-specific histone methylation in vitro and in vivo. Nat Cell Biol. (2019), 10.1038/s41556-019-0403-5. WB; Human. Read more (PubMed: 31659274)

Lu C et al. Histone H3K36M mutation and trimethylation patterns in chondroblastoma. Histopathology. (2019), 10.1111/his.13725. IHC; Human. Read more (PubMed: 30098026)

Fang D et al. Probing the Function of Oncohistones Using Mutant Transgenes and Knock-In Mutations. Methods Mol Biol. (2018), 10.1007/978-1-4939-8663-7_19. IHC-P; Human. Read more (PubMed: 30073537)

Rehkamper J et al. Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy. Oncotarget. (2018), 10.18632/oncotarget.25725. IHC-P; Human. Read more (PubMed: PMC6059026)

Frye J et al. H3F3 K36M Immunohistochemistry is a Useful Diagnostic Marker for Chondroblastoma in Small Biopsy Specimens. Mod Pathol. (2018), USCAP 2018 Abstracts-Bone & Soft Tissue Pathology (45-120). IHC-P; Human. Read more (USCAP 2018 Abstracts: 63: PubMed: 29551782)

Schaefer IM et al. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy. Cancer Cytopathol. (2018) 10.1002/cncy.22000. IHC-P; Human. Read more (PubMed: 29757500)

Amary MF et al. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma. Histopathology (2016) 10.1111/his.12945. IHC-P; Human. Read more (PubMed: 26844533)

Fang D et al. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. Science (2016) 10.1126/science.aae0065. ChIP; Human. Read more (PubMed: 27229140)

Jundt G et al. Chondroblastoma. Der Pathologe (2018) 10.1007/s00292-017-0397-3. IHC-P; Human Read more (PubMed: 29209799)

Amary F et al. Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement. Mod Pathol. (2019), 10.1038/s41379-019-0315-8. IHC; Human. Read more (PubMed: 31273315)
References for Histone H3.3 G34W Mutant antibody [RM263]Gong L et al H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors. Histol Histopathol. (2021), 10.14670/HH-18-264. IHC; Human. Read more (PubMed: 33021329)

Khazaei S et al. H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone. Cancer Discov. (2020), 10.1158/2159-8290.CD-20-0461. WB, IHC, ChIP-seq; Human. Read more (PubMed: 32967858)

Yamaga K et al. Successful Treatment with Denosumab of a Giant Cell Tumor of Bone in the Iliac Bone of an 84-Year-Old Man. Yonago Acta Med. (2020), 10.33160/yam.2020.08.013. IHC; Human. Read more (PubMed: 32884443)

Shibuya I et al. Immunohistochemical Analysis of the Distribution of RANKL-Expressing Cells and the Expression of Osteoclast-Related Markers in Giant Cell Tumor of Bone. Journal of Hard Tissue Biology. (2020), 10.2485/jhtb.29.137. IHC; Human. Read more (J-STAGE)

Papke D J et al. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma. Mod Pathol. (2020), 10.1038/s41379-020-0604-2. IHC; Human. Read more (PubMed: 32601382)

Ud Din N et al. Histomorphometric Analysis of Pre- and Post-Denosumab-Treated Giant Cell Tumor of Bone. Int J Surg Pathol. (2020), 10.1177/1066896920920716. IHC; Human. Read more (PubMed: 32429739)

Metovic J et al. Prognostic role of PD‑L1 and immune‑related gene expression profiles in giant cell tumors of bone. Cancer Immunol Immunother. (2020), 10.1007/s00262-020-02594-9. IHC; Human. Read more (PubMed: 32377818)

Fritchie K J et al. Xanthogranulomatous epithelial tumor: report of 6 cases of a novel, potentially deceptive lesion with a predilection for young women. Mod Pathol. (2020), 10.1038/s41379-020-0562-8. IHC; Human. Read more (PubMed: 32415263)

Brčić I et al. Giant Cell Tumor of Bone With Cartilage Matrix: A Clinicopathologic Study of 17 Cases. Am J Surg Pathol. (2020), 10.1097/PAS.0000000000001446. IHC; Human. Read more (PubMed: 32412716)

Leinauer B et al. Giant Cell Tumor of Bone – new aspects, new problems. Osteologie. (2020), 10.1055/a-1083-8923. IHC; Human. Read more (Thieme)

Treffel M et al. Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology. Am J Surg Pathol. (2020), 10.1097/PAS.0000000000001388. IHC-P (Dako Flex+Envision revelation system); Human. Read more (PubMed: 31651524)

Oliveira Filho S et al. Angiogenesis (WT1, CD31 and CD105) and mutation (Gene H3F3A) in central lesions of aggressive and non-aggressive giant cells. Dissertação (Mestrado em Odontologia). (2019), Universidade Federal de Goiás, Goiânia. IHC; Human. Read more (Dissertação)

Taniguchi Y et al. Anti-tumor Effects of Cyclolinopeptide on Giant-cell Tumor of the Bone. Anticancer Res. (2019), 10.21873/anticanres.13822. IF; Human. Read more (PubMed: 31704842)

Yoshida KI et al. Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone. Mod Pathol. (2019), 10.1038/s41379-019-0318-5. IHC; Human. Read more (PubMed: 31285528)

Venning VL et al. Poorly differentiated cutaneous squamous cell carcinoma with osteoclast¬like giant cell: A rare, aggressive variant. Clin Case Rep. (2019), 10.1002/ccr3.1955. IHC; Human. Read more (PubMed: 30847202)

Ito Y et al. Giant cell-rich osteosarcoma of the vertebra with murine double minute chromosome 2- and cyclin-dependent kinase 4-positive and histone H3F3A mutant p.Gly34Trp-negative immunophenotypes. Pathol Int. (2018), 10.1111/pin.12650. IHC; Human. Read more (PubMed: 29446514)

Shimizu J et al. Arthroscopic Resection for Benign Fibrous Histiocytoma in the Epiphysis of the Femur. Case Rep Orthop. (2018), 10.1155/2018/8030862. IHC; Human. Read more (PubMed: 30581643)

Li HR et al. USP6 gene rearrangement differentiates primary paranasal sinus solid aneurysmal bone cyst from other giant cell–rich lesions: report of a rare case. Hum Pathol. (2018), 10.1016/j.humpath.2017.11.018. IHC; Human. Read more (PubMed: 29217425)

Lindholm KE et al. Osteoclast-like giant cell rich carcinomas of the lung: a Clinicopathological, Immunohistochemical, and molecular study of three cases. Hum Pathol. (2019), 10.1016/j.humpath.2018.10.030. IHC; Human. Read more (PubMed: 30447297)

Lübbehüsen C et al. Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway. Sci Rep. (2019), 10.1038/s41598-019-42611-1. IHC-P, WB; Human. Read more (PubMed: 31015476)

Fellenberg J et al. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells. Cancer Lett. (2019), 10.1016/j.canlet.2019.02.001. IHC-P; Human. Read more (PubMed: 30742944)

Giesche, J. P et al. H3F3A mutated multicentric giant cell tumor of bone : A very rare primary bone disease. Pathologe. Springer Nature. (2018) 10.1007/s00292-018-0460-8. IHC-P; Human. Read more (PubMed: 30046846)

Lüke J. et al. New aspects on giant cell tumor of bone. Pathologe. Springer Nature. (2018) 10.1007/s00292-017-0391-9, IHC-P; Human. Read more (PubMed: 29110035)

Rehkamper J et al. Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy. Oncotarget. (2018), 10.18632/oncotarget.25725. IHC-P; Human. Read more (PubMed: PMC6059026)

Tsukamoto Y et al. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation. Pathol Res Pract. (2018) 10.1016/j.prp.2018.06.015. IHC-P; Human. Read more (PubMed: 29970305)

Patel V et al. Evaluation of H3.3 G34W expression in denosumabtreated giant cell tumor of bone and histologic mimics. Mod Pathol. (2018), USCAP 2018 Abstracts-Bone & Soft Tissue Pathology (45-120). IHC-P; Human. Read more (USCAP 2018 Abstracts: 101: PubMed: 29551782)

Schaefer IM et al. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy. Cancer Cytopathol. (2018) 10.1002/cncy.22000. IHC-P; Human. Read more (PubMed: 29757500)

Scotto di Carlo F et al. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location. BMC Cancer (2018) 10.1186/s12885-018-4291-z. IHC-P; Human, IF-P; Human. Read more (PubMed: 29609578)

Yamamoto H et al. Diagnostic utility of histone H3.3G34 W, G34R, and G34 V mutant-specific antibodies for giant cell tumors of bone. Human Pathology (2017) 10.1016/j.humpath.2017.11.020. IHC; Human. Read more (PubMed: 29241742)

Kato I et al. Giant Cell Tumours of Bone Treated with Denosumab: Histologic, Immunohistochemical, and H3F3A Mutation Analyses. Histopathology (2017) 10.1111/his.13448. IHC-P; Human. IF; Human. Read more (PubMed: 29206281)

Luke J et al. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant. Histopathology (2017) 10.1111/his.13190. IHC-P; Human. Read more (PubMed: 28211081)

Amary F et al. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone. AM J Surg Pathol. (2017) 10.1097/PAS.0000000000000859. IHC-P; Human. Read more (PubMed: 28505000)
References for Histone H3.3 G34R Mutant antibody [RM240]Nambiraja A et al C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center. Childs Nerv Syst. (2021), 10.1007/s00381-020-04973-0. IHC; Human. Read more (PubMed: 33236184)

Esteve-Codina A et al RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma. Clin Cancer Res. (2021), 10.1158/1078-0432.CCR-20-2141. IHC; Human. Read more (PubMed: 33106291)

Bressa RB et al Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants. Cell Stem Cell. (2021), 10.1016/j.stem.2021.01.016. IHC; Human. Read more (PubMed: 33631116)

Minasi S et al Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma. Childs Nerc Syst. (2020), 10.1007/s00381-020-04933-8. IHC; Human. Read more (PubMed: 33128602)

Pathania M et al. H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas Cancer Cell (2017) 10.1016/j.ccell.2017.09.014. IHC-P; Human. Read more (PubMed: 29107533)

Yamamoto H et al. Diagnostic utility of histone H3.3G34 W, G34R, and G34 V mutant-specific antibodies for giant cell tumors of bone. Human Pathology (2017) 10.1016/j.humpath.2017.11.020. IHC; Human. Read more (PubMed: 29241742)
References for Histone H3.3 G34V Mutant antibody [RM307]Nambiraja A et al C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center. Childs Nerv Syst. (2021), 10.1007/s00381-020-04973-0. IHC; Human. Read more (PubMed: 33236184)

Minasi S et al Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma. Childs Nerc Syst. (2020), 10.1007/s00381-020-04933-8. IHC; Human. Read more (PubMed: 33128602)

Sangatsuda Y et al. Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors. Neuro Oncol. (2020), 10.1093/neuonc/noaa222.836. WB; Human. Read more (PubMed: PMC7715604)

Ito Y et al. Giant cell-rich osteosarcoma of the vertebra with murine double minute chromosome 2- and cyclin-dependent kinase 4-positive and histone H3F3A mutant p.Gly34Trp-negative immunophenotypes. Pathol Int. (2018), 10.1111/pin.12650. IHC; Human. Read more (PubMed: 29446514)

Yamamoto H et al. Diagnostic utility of histone H3.3G34 W, G34R, and G34 V mutant-specific antibodies for giant cell tumors of bone. Human Pathology (2017) 10.1016/j.humpath.2017.11.020. IHC; Human. Read more (PubMed: 29241742)
References for BRAF V600E Mutant antibody [RM8]Labib M et al. Tracking the expression of therapeutic protein targets in rare cells by antibody-mediated nanoparticle labelling and magnetic sorting. Nat Biomed Eng. (2020), 10.1038/s41551-020-0590-1. FC; Human. Read more (PubMed: 32719513)

Crespo-Rodriguez E et al. Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer. J Immunother Cancer. (2020), 10.1136/jitc-2020-000698. WB; Human. Read more (PubMed: 32759235)

Martin AM et al. PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status. J Neuropathol Exp Neurol. (2020), 10.1093/jnen/nlz119. WB; Human. Read more (PubMed: 31819973)

Shirsat PM et al. Low frequency of BRAF V600E immunoexpression in mandibular ameloblastomas: An institutional study. J Oral Maxillofac Pathol. (2018), 10.4103/jomfp.JOMFP_174_17. IHC; Human. Read more (PubMed: 30651680)

Usman H et al. Result Analysis of BRAF V600E Gene Mutation Using Molecular and Immunohistochemistry Detection in Acral Malignant Melanoma. Asian Pacific Journal of Cancer Care. (2018), 10.31557/APJCC.2018.3.3.43. IHC; Human. Read more (WAOCP)

Hansen CH et al. Nanoswitch-linked immunosorbent assay (NLISA) for fast, sensitive, and specific protein detection. Proc Natl Acad Sci U S A. (2017), 10.1073/pnas.1708148114. IHC; Human. Read more (PubMed: 28893984)

Krishnamurthy A et al. Clinical utility of immunohistochemistry using the novel anti-BRAF V600E antibody (clone RM8) for detection of the BRAF V600E mutant protein in papillary thyroid cancers. Int J Mol ImmunoOncol. (2018) 10.18203/issn.2456-3994.IntJMolImmunoOncol20180471. IHC-P; Human. Read more (IJMIO: ISSN: 2456-3994)

Gouravan S et al. Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas. Int J Mol Sci. (2018) 10.3390/ijms19040969. WB; Human. Read more (PubMed: 29570692)

Yang H et al. Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma. Oncogene (2017) 10.1038/onc.2016.526. WB; Human. Read more (PubMed: 28263969)

ZM Shaban et al. BRAFV600E Mutation in Gliomas in Iraqi Patients Immunohistochemical Study. ijcocr (2017) 10.11648/j.ijcocr.20170206.11. IHC; Human. Read More
References for Phosphotyrosine Rabbit Monoclonal Antibody [RM111]
Sun Y et al. Neuregulin-1/ErbB4 Signaling Regulates Visual Cortical Plasticity Neuron (2016) 10.1016/j.neuron.2016.08.033. IHC; Mouse. Read more (PubMed: 27641496)

References for 5-hydroxymethylcytosine (5-hmC) antibody [RM236]Siref AB et al. Diagnostic utility of dual 5-hmC/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the work-up of sentinel lymph node specimen. J Cutan Pathol. (2019) 10.1111/cup.13412, IHC; Human Read more (PubMed: 30632191)

J Reichmann et al. Dual spindle formation in zygotes keeps parental genomes apart in early mammalian embryos, bioRxiv (2017) 10.1101/198275. IF; Mouse. Read more
References for Histone H3.3 Rabbit Monoclonal Antibody [RM190]Hinchcliffe EH et al. Chromosome missegregation during anaphase triggers p53 cell cycle arrest through histone H3.3 Ser31 phosphorylation Nat Cell Biol. (2016) 10.1038/ncb3348. IF; Human, Monkey. Read more (PubMed: 27136267)
References for Acetyl-Histone H3 (Lys9) antibody [RM161]Li Y et al. Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas. Proc Natl Acad Sci USA. (2016) 113(50):14402-14407. ChIP; Human.Read more (PubMed: 27911794)

Bulut-Karslioglu A et al. The Transcriptionally Permissive Chromatin State of Embryonic Stem Cells Is Acutely Tuned to Translational Output. Cell Stem Cell. (2018) 10.1016/j.stem.2018.02.004. WB; Human. Read more (PubMed: 29499153)
References for Acetyl-Histone H3 (Lys18) antibody [RM166]Li Y et al. Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas. Proc Natl Acad Sci USA. (2016) 113(50):14402-14407. ChIP; Human.Read more (PubMed: 27911794)

Cheung P et al. Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging. Cell. (2018) 10.1016/j.cell.2018.03.079. Mass Cytometry; Human.Read more (PubMed: 29706550)

References for Acetyl-Histone H3 (Lys56) antibody [RM179]Li Y et al. Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas. Proc Natl Acad Sci USA. (2016) 113(50):14402-14407. ChIP; Human.Read more (PubMed: 27911794)
References for Trimethyl-Histone H3 (Lys4) antibody [RM137]Shah RN et al Examining the Roles of H3K4 Methylation States with Systematically Characterized Antibodies. Mol Cell. (2018), 10.1016/j.molcel.2018.08.015. ICeChIP. Read more (PubMed: 30244833)

Lu P et al. Genome encode analyses reveal the basis of convergent evolution of fleshy fruit ripening. Nat Plants. (2018) 10.1038/s41477-018-0249-z. ChIP; Plant. Read more (PubMed: 30250279)
References for Trimethyl-Histone H3 (Lys27) antibody [RM175]Tsai CC et al. Overexpression of Histone H3 Lysine 27 Trimethylation Is Associated With Aggressiveness and Dedifferentiation of Thyroid Cancer. Endocr Pathol. (2019), 10.1007/s12022-019-09586-1. IHC; Human. Read more (PubMed: 31396854)


Lu P et al. Genome encode analyses reveal the basis of convergent evolution of fleshy fruit ripening. Nat Plants. (2018) 10.1038/s41477-018-0249-z. ChIP; Plant. Read more (PubMed: 30250279)
References for Acetyl-Histone H3 (Lys27) antibody [RM172]Mondal B et al The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth. Elife. (2020), 10.7554/eLife.57519. WB; Human. Read more (PubMed: 32297854)

Li Y et al. Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas. Proc Natl Acad Sci USA. (2016) 113(50):14402-14407. ChIP; Human.Read more (PubMed: 27911794)

Bulut-Karslioglu A et al. The Transcriptionally Permissive Chromatin State of Embryonic Stem Cells Is Acutely Tuned to Translational Output. Cell Stem Cell. (2018) 10.1016/j.stem.2018.02.004. WB; Human. Read more (PubMed: 29499153)

Lu P et al. Genome encode analyses reveal the basis of convergent evolution of fleshy fruit ripening. Nat Plants. (2018) 10.1038/s41477-018-0249-z. ChIP; Plant. Read more (PubMed: 30250279)
References for Acetyl-Histone H3 (Lys23) antibody [RM169]Cheung P et al. Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging. Cell. (2018) 10.1016/j.cell.2018.03.079. Mass Cytometry; Human.Read more (PubMed: 29706550)
References for Trimethyl-Histone H3 (Lys36) antibody [RM155]Cheung P et al. Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging. Cell. (2018) 10.1016/j.cell.2018.03.079. Mass Cytometry; Human.Read more (PubMed: 29706550)
References for Dimethyl-Histone H3 (Lys9) antibody [RM151]Xiong H et al. Inhibition of Histone Methyltransferase G9a Attenuates Noise-Induced Cochlear Synaptopathy and Hearing Loss. J Assoc Res Otolaryngol. (2019), 10.1007/s10162-019-00714-6. ICC, IHC; Human. Read more (PubMed: 30710318)
References for Human Ig Lambda Light Chain antibody [RM127]Cheung P et al. Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging. Cell. (2018) 10.1016/j.cell.2018.03.079. Mass Cytometry; Human.Read more (PubMed: 29706550)
References for Human IgG1 antibody [RM117]Harel E et al Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes. J Transplantation. (2020), 10.1097/TP.0000000000002930. IHC; Human. Read more (PubMed: 31449183)

Sulka KB et al. Lyme Disease-Associated IgG4 Autoantibodies Correlate with Synovial Pathology in Antibiotic-Refractory Lyme Arthritis. Arthritis Rheumatol. (2018) 10.1002/art.40566. IHC-P; Human. Read more (PubMed: 29790305)
References for Human IgG2 antibody [RM118]Sulka KB et al. Lyme Disease-Associated IgG4 Autoantibodies Correlate with Synovial Pathology in Antibiotic-Refractory Lyme Arthritis. Arthritis Rheumatol. (2018) 10.1002/art.40566. IHC-P; Human. Read more (PubMed: 29790305)
References for Human IgG3 antibody [RM119]Sulka KB et al. Lyme Disease-Associated IgG4 Autoantibodies Correlate with Synovial Pathology in Antibiotic-Refractory Lyme Arthritis. Arthritis Rheumatol. (2018) 10.1002/art.40566. IHC-P; Human. Read more (PubMed: 29790305)
References for Human IgG4 antibody [RM120]Sulka KB et al. Lyme Disease-Associated IgG4 Autoantibodies Correlate with Synovial Pathology in Antibiotic-Refractory Lyme Arthritis. Arthritis Rheumatol. (2018) 10.1002/art.40566. IHC-P; Human. Read more (PubMed: 29790305)
References for mPEG antibody [RM105]Lam SK et al. Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma. Oncogenesis. (2019), 10.1038/s41389-019-0128-0. WB. Read more (PubMed: 30808864)

Lam SK et al. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts. Respir Res. 10.1186/s12931-017-0564-3 (2017). WB, IF IHC. Read more (PubMed: 28464918)

Lam SK et al. Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models. Oncol Rep. 10.3892/or.2018.6598 (2018). WB, DotBlot Read more (PubMed: 30066894)

Xu Shi et al. Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer. Cancer Sci. 10.1111/cas.13782 (2018). WB, IF Read more (PubMed: 30155941)

McCallen J et al. Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone. ACS Biomater. Sci. Eng. (2017), 10.1021/acsbiomaterials.7b00147. ELISA, Dot Blot; Human. Read more (PubMed: 7b00147)
References for HA-Tag antibody [RM305]Williams JL et al. Conditional Synaptic Vesicle Markers for Drosophila. G3 (Bethesda). (2019) 10.1534/g3.118.200975. IHC; Drosophila. Read more (PubMed: 30635441)
References for Spastin antibody [RM346]Chang C et al. Spastin tethers lipid droplets to peroxisomes and directs fatty acid trafficking through ESCRT-III. bioRxiv (2019), 10.1101/544023. WB; Mouse. Read more
References for Biotin Mouse IgG1 antibody [RM106]Liu F et al T cell-derived soluble glycoprotein GPIbα mediates PGE 2 production in human monocytes activated with the vaccine adjuvant MDP. Sci Signal. (2019), 10.1126/scisignal.aat6023. WB; Human. Read more (PubMed: 31594856)
References for β-Actin antibody (RM112)Jevtić P et al The nucleoporin ELYS regulates nuclear size by controlling NPC number and nuclear import capacity. EMBO Rep. (2019), 10.15252/embr.201847283. WB; Human. Read more (PubMed: 31085625)

Wang G et al. Structural plasticity of actin-spectrin membrane skeleton and functional role of actin and spectrin in axon degeneration. Elife. (2019), 10.7554/eLife.38730. WB; Human. Read more (PubMed: 31042147)

Mukherjee RN et al. Reticulon 4a promotes exocytosis in mammalian cells. Mol Biol Cell. (2019), 10.1091/mbc.E19-03-0159. WB; Human. Read more (PubMed: 31318320)
References for 5-mC antibody (RM231) Logsdon GA et al The structure, function and evolution of a complete human chromosome 8. Nature. (2021), 10.1038/s41586-021-03420-7. IF; Human. Read more (PubMed: 33828295)

Kojima N et al. Immobilization of DNA with nitrogen mustard-biotin conjugate for global epigenetic analysis. Anal Chim Acta. (2018), 10.1016/j.aca.2018.09.008. ELISA; Human. Read more (PubMed: 30392657)
References for Acetyl-Histone H3 (Lys4) antibody (RM149) Mondal B et al The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth. Elife. (2020), 10.7554/eLife.57519. WB; Human. Read more (PubMed: 32297854)
References for Acetyl-Histone H3 (Lys79) antibody (RM156) Mondal B et al The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth. Elife. (2020), 10.7554/eLife.57519. WB; Human. Read more (PubMed: 32297854)
References for Acetyl-Histone H4 (Lys20) antibody (RM205) Mondal B et al The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth. Elife. (2020), 10.7554/eLife.57519. WB; Human. Read more (PubMed: 32297854)
References for Monomethyl-Histone H3 (Lys4) antibody (RM140)Shah RN et al Examining the Roles of H3K4 Methylation States with Systematically Characterized Antibodies. Mol Cell. (2018), 10.1016/j.molcel.2018.08.015. ICeChIP. Read more (PubMed: 30244833)
References for SATB2 antibody (RM365)Zhu Z et al Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin α v β 5 Axis. Mol Cell. (2020), 10.1016/j.stem.2019.11.016. WB; Human. Read more (PubMed: 31956038)
References for Surfactant Protein A (SP-A) antibody (RM334)Szekely L et al Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of Covid-19 death. Heliyon. (2021), 10.1016/j.heliyon.2021.e07134. IHC; Human. Read more (PubMed: 34056141)
References for RevMAb ServiceMishra I et al Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. Elife. (2021), 10.7554/eLife.63784. mAb Production Service; Human. Read more (PubMed: 33904407)

Bu D et al. Human endotrophin as a driver of malignant tumor growth. JCI Insight. (2019), 10.1172/jci.insight.125094. Human. Read more (PubMed: 30896449)